source
- Stem cell advocates anticipate FDA roundtables as peptide therapies gain regulatory footholdAt PepMed 2026, a conference focused on peptide medicines, stem cell entrepreneur Chuck Meeker said he expects the FDA to hold a series of roundtables on regenerative therapies before year‑end. He…
- FDA warns Evolus over misleading Instagram claims about JeuveauThe FDA's Office of Prescription Drug Promotion sent an untitled warning letter to Evolus, the maker of the injectable cosmetic product Jeuveau. The letter says the company exaggerated the drug’s…